Increased levels of NF-kappaB inhibitors (IkappaBalpha and IkappaBgamma) in the intestinal mucosa of Crohn's disease patients during infliximab treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples